DK0884329T3 - Anti-idiotypisk antistof, som inducerer en immunreaktion mod et glycosphingolipid, samt anvendelse deraf - Google Patents

Anti-idiotypisk antistof, som inducerer en immunreaktion mod et glycosphingolipid, samt anvendelse deraf

Info

Publication number
DK0884329T3
DK0884329T3 DK98108374T DK98108374T DK0884329T3 DK 0884329 T3 DK0884329 T3 DK 0884329T3 DK 98108374 T DK98108374 T DK 98108374T DK 98108374 T DK98108374 T DK 98108374T DK 0884329 T3 DK0884329 T3 DK 0884329T3
Authority
DK
Denmark
Prior art keywords
glycosphingolipid
immune response
induces
idiotypic antibody
provides
Prior art date
Application number
DK98108374T
Other languages
English (en)
Inventor
Paul B Chapman
Alan N Houghton
Original Assignee
Sloan Kettering Inst Cancer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Inst Cancer filed Critical Sloan Kettering Inst Cancer
Application granted granted Critical
Publication of DK0884329T3 publication Critical patent/DK0884329T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6873—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting an immunoglobulin; the antibody being an anti-idiotypic antibody
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK98108374T 1989-05-25 1990-05-25 Anti-idiotypisk antistof, som inducerer en immunreaktion mod et glycosphingolipid, samt anvendelse deraf DK0884329T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35703789A 1989-05-25 1989-05-25

Publications (1)

Publication Number Publication Date
DK0884329T3 true DK0884329T3 (da) 2003-10-20

Family

ID=23404043

Family Applications (2)

Application Number Title Priority Date Filing Date
DK90909554T DK0473721T3 (da) 1989-05-25 1990-05-25 Antiidiotypisk antistof, som fremkalder en immunreaktion med et glycosphingolipid, og anvendelse deraf
DK98108374T DK0884329T3 (da) 1989-05-25 1990-05-25 Anti-idiotypisk antistof, som inducerer en immunreaktion mod et glycosphingolipid, samt anvendelse deraf

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK90909554T DK0473721T3 (da) 1989-05-25 1990-05-25 Antiidiotypisk antistof, som fremkalder en immunreaktion med et glycosphingolipid, og anvendelse deraf

Country Status (9)

Country Link
US (1) US5529922A (da)
EP (3) EP0473721B1 (da)
JP (1) JP3392860B2 (da)
AT (2) ATE243713T1 (da)
CA (1) CA2057010C (da)
DE (3) DE69034087T2 (da)
DK (2) DK0473721T3 (da)
ES (2) ES2127186T3 (da)
WO (1) WO1990014104A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6805862B1 (en) 1989-05-25 2004-10-19 Sloan-Kattering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US6432402B1 (en) 1989-05-25 2002-08-13 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US5268454A (en) 1991-02-08 1993-12-07 La Jolla Pharmaceutical Company Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
US20030035797A1 (en) * 1992-01-27 2003-02-20 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof
US5874085A (en) * 1993-11-10 1999-02-23 Henry M. Jackson Foundation For The Advancement Of Military Medicine Vaccine for enhanced production of IgA antibodies
CU22420A1 (es) * 1993-12-29 1996-01-31 Centro Inmunologia Molecular Composicion vacunal para el desarrollo de una respuesta contra gangliosidos n glicolilados y su uso para el tratamiento del cancer
US6149921A (en) * 1993-12-29 2000-11-21 Centro De Inmunologia Molecular Vaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatment
US5977316A (en) * 1995-01-17 1999-11-02 The Board Of Trustees Of The University Of Kentucky Monoclonal antibody 1A7 and related polypeptides
US5935821A (en) 1995-01-17 1999-08-10 Board Of Trustees Of The University Of Kentucky Polynucleotides related to monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5612030A (en) * 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma
US5792455A (en) * 1996-03-21 1998-08-11 Sloan-Kettering Institute For Cancer Research Anti-idiotypic antibody vaccines
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
ES2434961T5 (es) 1998-04-20 2018-01-18 Roche Glycart Ag Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
US6989276B2 (en) 2001-05-10 2006-01-24 Battelle Energy Alliance, Llc Rapid classification of biological components
USRE46351E1 (en) 2001-05-10 2017-03-28 Battelle Energy Alliance, Llc Antibody profiling sensitivity through increased reporter antibody layering
EP2180044A1 (en) 2001-08-03 2010-04-28 GlycArt Biotechnology AG Antibody glycosylation variants having increased anti-body-dependent cellular cytotoxicity
WO2007048092A2 (en) * 2005-10-17 2007-04-26 Spidertech, A Division Of Stoecker & Associates, A Subsidiary Of The Dermatology Center, Llc Immunoassay for venom detection including noninvasive sample collection
US20080286881A1 (en) * 2007-05-14 2008-11-20 Apel William A Compositions and methods for combining report antibodies
WO2011022103A2 (en) * 2009-08-18 2011-02-24 Medical College Of Georgia Research Institute, Inc. Ganglioside epitopes for treating guillain-barre syndrome
US8969009B2 (en) * 2009-09-17 2015-03-03 Vicki S. Thompson Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual
US9410965B2 (en) * 2009-09-17 2016-08-09 Battelle Energy Alliance, Llc Identification of discriminant proteins through antibody profiling, methods and apparatus for identifying an individual

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE32833E (en) * 1982-03-01 1989-01-17 President And Fellows Of Harvard College Screening vaccines and immunization process
EP0134868A1 (en) * 1983-08-26 1985-03-27 Anda Biologicals Unicellular organisms activated by glutaraldehyde as solid carriers for sensitizing agents and uses of sensitized unicellular organisms
US5614610A (en) * 1984-12-21 1997-03-25 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
US4918164A (en) * 1987-09-10 1990-04-17 Oncogen Tumor immunotherapy using anti-idiotypic antibodies
AU603585B2 (en) * 1986-05-07 1990-11-22 Sloan-Kettering Institute For Cancer Research Vaccine for stimulating or enhancing production of antibodies directed against GM2
US4849509A (en) * 1987-02-20 1989-07-18 The Wistar Institute Monoclonal antibodies against melanoma-associated antigens and hybrid cell lines producing these antibodies
IT1217314B (it) * 1987-02-20 1990-03-22 Sclavo Spa Nonapeptide sintetico ad attivita'adiuvante capace di potenziare in vivo la risposta anticorporale
AU1711888A (en) * 1987-04-24 1988-12-02 Biogen, Inc. Immunotherapeutic methods and compositions
US4900547A (en) * 1987-10-23 1990-02-13 University Of British Columbia Method to immunize mammals against tumors

Also Published As

Publication number Publication date
DK0473721T3 (da) 1999-08-23
ATE243713T1 (de) 2003-07-15
DE69032855T2 (de) 1999-08-12
US5529922A (en) 1996-06-25
JP3392860B2 (ja) 2003-03-31
CA2057010A1 (en) 1990-11-26
DE69034087D1 (de) 2003-07-31
EP0884329A1 (en) 1998-12-16
ES2207768T3 (es) 2004-06-01
EP0884329B1 (en) 2003-06-25
EP0473721A1 (en) 1992-03-11
DE69032855D1 (de) 1999-02-04
DE69034087T2 (de) 2004-05-06
WO1990014104A1 (en) 1990-11-29
CA2057010C (en) 2002-08-06
HK1014658A1 (en) 1999-09-30
DE473721T1 (de) 1993-04-29
ATE174799T1 (de) 1999-01-15
JPH05500600A (ja) 1993-02-12
EP0473721A4 (da) 1994-03-23
ES2127186T3 (es) 1999-04-16
EP1334984A1 (en) 2003-08-13
EP0473721B1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
DK0884329T3 (da) Anti-idiotypisk antistof, som inducerer en immunreaktion mod et glycosphingolipid, samt anvendelse deraf
FI914908A0 (fi) Ny monoklonal antikropp med ny antigen relaterad till humana tumoerer.
FI20011187L (fi) Antigeenin kanssa käytettäväksi tarkoitettuja koostumuksia
DE68914244D1 (de) Monoklonaler Antikörper.
DE69004014D1 (de) Reibverbindungsgerät.
IT8020166A0 (it) Procedimento e dispositivo per fissare pastiglie d'usura ad attrito.
ITMI920678A1 (it) Dispositivo di ancoraggio, per esempio per componenti di mobili e simili
DE69010669D1 (de) Reibbelag und belagträgerscheibe.
DE3766688D1 (de) Daempfungsvorrichtung.
FI910572A0 (fi) Regnmaetare med anordning som paovisar tilltaeppning.
NO894444L (no) Anti-fucosylceramid monoklonalt antistoff.
DE69014132D1 (de) Reibbeläge und trägereinheit.
DK0409495T3 (da) Sammensætninger til friktionselementer
NO892773L (no) Glideslipeinnretning.
DK336687A (da) Monoklonale antistoffer mod pseudomonas aeruginosa flagella
IT8920033A0 (it) Dispositivo di ritenuta per cintura di sicurezza.
IT8121662A0 (it) Dispositivo meccanico di bloccaggio per attrito.
FI862834L (fi) Friktionsmaethjul.
FR2697387B1 (fr) Dispositif destiné à entretenir un mouvement alternatif ou pendulaire.
DE59009674D1 (de) Reibscheibe.
MX9202642A (es) Anticuerpos monoclonales y antigeno para melanoma humano.
DE69014020D1 (de) Dämpfungsscheibe.
FR2583973B2 (fr) Dispositif de pesage de personnes sur siege de w.c.
DE69013938D1 (de) Sicherheitsgurtvorrichtung.
DE4090200T1 (de) Daempfungsscheibe